[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1534995452835{padding-right: 40px !important;padding-left: 40px !important;}”][vc_column][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner width=”1/6″][/vc_column_inner][vc_column_inner width=”2/3″][vc_column_text]Click the image below to read about GB Sciences in this March 23 story in Benzinga[/vc_column_text][vc_empty_space height=”22px”][vc_single_image image=”4389″ img_size=”full” alignment=”center” onclick=”custom_link” img_link_target=”_blank” qode_css_animation=”” link=”https://www.benzinga.com/markets/cannabis/19/03/13412545/the-week-in-cannabis-safe-banking-act-stocks-in-red-ipos-high-tech-a”][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][/vc_row_inner][vc_empty_space height=”20px”][/vc_column][/vc_row]